All articles by Srivani Venna

  1. Lilly and AstraZeneca receive FDA fast track designation for Alzheimer’s drug

    Eli Lilly and AstraZeneca have received fast track designation from the US Food and Drug Administration (FDA) for AZD3293, an…
    Read More…

    22 Aug
  2. India develops world’s first leprosy vaccine

    India has developed the world’s first leprosy vaccine, which is soon to be planned for trials within five districts of…
    Read More…

    21 Aug
  3. Genekam develops therapeutic molecule candidate against Zika viruses

    German-based company Genekam Biotechnology has developed the first potential therapeutic molecule candidate against Zika viruses. The Zika virus infects pregnant…
    Read More…

    21 Aug
  4. US FDA approves Cosentyx for ankylosing spondylitis and psoriatic arthritis treatment

    Swiss drug maker Novartis has secured approvals from the US Food and Drug Administration (FDA) for injectable medication Cosentyx for…
    Read More…

    17 Jan
  5. Actelion confirms preliminary discussions to acquire ZS Pharma

    Switzerland-based drugmaker Actelion has confirmed the initiation of preliminary discussions with US-based ZS Pharma over a potential transaction. ZS Pharma…
    Read More…

    10 Sep
  6. Antenatal iron supplementation does not increase malaria risk, says study

    A new study has found that daily iron supplementation during pregnancy in a malaria-endemic region of Kenya did not result…
    Read More…

    8 Sep
  7. Cancer patients miss out on personalised treatments in England: Cancer Research UK

    A new report commissioned by Cancer Research UK has revealed that thousands of cancer patients in England are not being…
    Read More…

    20 Aug
  8. Bayer to support DNDi on oral drug development for river blindness

    Bayer HealthCare has agreed to provide the ingredient emodepside to support Drugs for Neglected Diseases initiative (DNDi) in its effort…
    Read More…

    10 Dec
Close
Close
Close

Go Top